Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 08 04:00PM ET
27.88
Dollar change
+0.13
Percentage change
0.47
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y20.78% Shs Outstand Perf Week-1.06%
SponsorTema ETF Type Tagsequity Return% 3Y- Total Holdings49 Perf Month-3.43%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM48.40M Perf Quarter-0.04%
Index- Average Maturity Tags- Return% 10Y NAV% Perf Half Y2.05%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year20.64%
Active/Passive Quant Type Tags- Flows% 1M1.19% 52W Range21.46 - 30.11 Perf YTD5.62%
Dividend TTM0.13 (0.48%) ESG Type Tags- Flows% 3M6.38% 52W High-7.40% Beta1.20
Dividend Ex-DateDec 13, 2023 Dividend Type Sector/Theme Flows% YTD157.08% 52W Low29.93% ATR (14)0.42
Expense0.75% Structure Type Region Flows% 1Y RSI (14)40.33 Volatility0.68% 1.13%
Option/ShortNo / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.29 Prev Close27.75
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume5.14K Price27.88
SMA20-2.45% SMA50-2.99% SMA2000.96% Trades Volume1,470 Change0.47%
Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.